Brain death due to neuroaspergillosis in a patient with COVID-19.
Rev Esp Anestesiol Reanim (Engl Ed)
; 69(9): 592-596, 2022 11.
Article
in English
| MEDLINE | ID: covidwho-2061811
ABSTRACT
Co-infections between SARS-CoV-2 and other pathogens is an important consideration for the treatment of patients with COVID-19. Aspergillus infections are part of this consideration since they present high morbidity and mortality. We present the case of a patient with COVID-19 and Aspergillus Fumigatus coinfection that evolves with brain death due to multiple heterogeneous lesions in the brain, which after a post-mortem biopsy found pathological lesions compatible with Aspergillus.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Neuroaspergillosis
/
COVID-19
Type of study:
Case report
Topics:
Long Covid
Limits:
Humans
Language:
English
Journal:
Rev Esp Anestesiol Reanim (Engl Ed)
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS